MedTrace Logo

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice

NCT02454803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1004

Last updated 2019-08-05

No results posted yet for this study

Summary

The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.

Conditions

  • Upper Limb Spasticity

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-06-03
Completion
2019-06-03

Countries

  • United States
  • Australia
  • Austria
  • Brazil
  • France
  • Germany
  • Hong Kong
  • Italy
  • Mexico
  • Philippines
  • Poland
  • Portugal
  • Russia
  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454803 on ClinicalTrials.gov